期刊文献+

甲磺酸伊马替尼治疗慢性粒细胞白血病33例疗效观察 被引量:1

下载PDF
导出
摘要 目的:探讨甲磺酸伊马替尼治疗慢性粒细胞白血病的临床效果。方法:采用回顾性分析的方法,分析我院收治的慢性粒细胞白血病患者临床资料,依据治疗方式不同分为观察组和对照组。结果:观察组临床治疗总缓解率明显高于对照组,同时恶心呕吐、下肢浮肿、皮疹、肝功能异常不良反应发生率均明显低于对照组(P<0.05),差异均有统计学意义。结论:甲磺酸伊马替尼治疗慢性粒细胞白血病的临床疗效良好,不良反应少,值得临床推广应用。
出处 《航空航天医药》 2010年第12期2234-2235,共2页 Aerospace Medicine
  • 相关文献

参考文献3

二级参考文献29

  • 1干定云,陈燕.慢性粒细胞白血病分子靶向治疗的新进展[J].临床血液学杂志,2006,19(3):190-192. 被引量:20
  • 2江倩,陈珊珊,江滨,江浩,丘镜滢,刘艳荣,张艳,秦亚溱,陆颖,黄晓军,陆道培.甲磺酸伊马替尼治疗慢性粒细胞白血病慢性期100例追踪观察[J].中华血液学杂志,2006,27(11):721-726. 被引量:39
  • 3王俊,赵谢兰,王光平,张维婕,谢俊明,程英妮,陈方平.格列卫治疗进展期慢粒白血病的临床观察[J].临床血液学杂志,2007,20(1):11-13. 被引量:7
  • 4龙轶,张学美,聂波,李惠民.格列卫联合异基因外周血造血干细胞移植治疗急变期慢性粒细胞白血病2例[J].临床血液学杂志,2007,20(2):117-118. 被引量:5
  • 5Talpaz M,Silver RT, Druker BJ, et al. Imatinib induces hematologic and cytogenetic response in patients with accelerated phase chronic myeloid leukemia results of a phase 2 study [J]. Blood, 2002, 99:1928-1937. 被引量:1
  • 6Sawyers C, Hochhaus A, Felaman E, et al. Imatinib patients with chronic myeloid leukemia in myeloid crisis updated results of a phase 2 study[J]. Blood, 2001,98:845. 被引量:1
  • 7Michele B, Giuseppe S, Godman J, et al. Evolving concepts in the management of chronic myeloid leukemia:recommendations from an expert panel on behalf of the European Leukemia Net [J]. Blood, 2006,108 : 1809-1820. 被引量:1
  • 8Cervantes F, Hernandez-Boluda JC, Steegmann JL, et al. Imatinih mesylate therapy of chronic phase chronic myeloid leukemia resistence or intolerant to interferon: results and prognostic factors for response and progression free survival in 150 patients[J]. Hamatologica, 2003,88 :1117-1122. 被引量:1
  • 9Gambacorti C, Talpaz M, Sawyers C, et al. Five years follow- up results of a phase Ⅱ trial in patients with late chronic phase chronic myeloid leukemia treated with imatinib who are intolerant of interferon-α[J]. Blood, 2005,106 : 1072-1089. 被引量:1
  • 10Silver RT, Talpaz M, Sawyers CL, et al. Four years of follow- up of 1 027 patients with late chronic phase,accelerated phase,or blast crisis chronic myeloid leukemia treated with imatinib in three Iarge phaselltrials[J]. Blood, 2004,104 : 11-23. 被引量:1

共引文献15

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部